Avestar Capital, LLC Axonics, Inc. Transaction History

Avestar Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$43.74 - $62.76 $300,581 - $431,286	-6,872 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$50.01 - $73.35 $924,684 - $1.36 Million	-18,490 Reduced 72.9%	6,872 $385,000
Q3 2021 Nov 09, 2021	BUY	$59.21 - $78.66 $41,447 - $55,062	700 Added 2.84%	25,362 $1.65 Million
Q2 2021 Aug 03, 2021	BUY	$51.39 - $66.9 $208,951 - $272,015	4,066 Added 19.74%	24,662 $1.56 Million
Q1 2021 May 03, 2021	BUY	$49.14 - $59.89 $461,228 - $562,127	9,386 Added 83.73%	20,596 $1.3 Million
Q4 2020 Feb 01, 2021	BUY	$42.19 - $51.5 $196,352 - $239,681	4,654 Added 70.99%	11,210 $560,000
Q3 2020 Oct 29, 2020	BUY	$35.33 - $51.04 $231,623 - $334,618	6,556 New	6,556 $327,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.